Lord, Abbett & Co
SGMO

Lord, Abbett & Co’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Lord, Abbett & Co’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-227,529
Closed -$3.46M – 948
2014
Q4 		$3.46M Sell
227,529
-59,138
-21% -$718K 0.01% 789
2014
Q3 		$3.09M Sell
286,667
-203,649
-42% -$2.66M 0.01% 825
2014
Q2 		$7.49M Buy
490,316
+222,190
+83% +$3.2M 0.02% 716
2014
Q1 		$4.85M Buy
268,126
+64,159
+31% +$1.24M 0.01% 797
2013
Q4 		$2.83M Buy
+203,967
New +$2.35M 0.01% 941

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Lord, Abbett & Co's SGMO Position: Q1 2015 in Review

Lord, Abbett & Co sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2015, closing a stake of 227,529 shares — an estimated $3.46M sold.

Lord, Abbett & Co first reported a position in SGMO in Q4 2013 and held it in 5 quarters. The position peaked at $7.49M in Q2 2014. 171 funds tracked by Wall St. Rank hold SGMO as of Q1 2015.

  • Lord, Abbett & Co reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2015 after selling out during the quarter.
  • Lord, Abbett & Co sold 227,529 SANGAMO THERAPEUTICS INC shares in Q1 2015, an estimated $3.46M.
  • Lord, Abbett & Co first reported a position in SANGAMO THERAPEUTICS INC in Q4 2013 and held it in 5 quarters.
  • Lord, Abbett & Co's SANGAMO THERAPEUTICS INC position peaked at $7.49M in Q2 2014.
  • 171 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2015.

Based on Lord, Abbett & Co's 13F filing for Q1 2015, filed 15 May 2015.